• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C反应蛋白、白细胞介素-6和D-二聚体在预测2019冠状病毒病严重程度中的作用:一项初步研究。

Role of C-reactive protein, IL-6, and D-dimers in prediction of severity of coronavirus disease 2019: A pilot study.

作者信息

Jahagirdar Pramod, Vaishnav Kalpesh, Sarathy Niharika Abhay, Singh Harneet, Kumia Komal, Banerjee Abhishek

机构信息

Department of Dentistry, Karnavati School of Research, Gandhinagar, Gujarat, India.

Department of Prosthodontics, Crown, and Bridge, Karnavati School of Dentistry, Gujarat, India.

出版信息

J Oral Maxillofac Pathol. 2024 Apr-Jun;28(2):205-210. doi: 10.4103/jomfp.jomfp_28_24. Epub 2024 Jul 11.

DOI:10.4103/jomfp.jomfp_28_24
PMID:39157833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11329092/
Abstract

BACKGROUND

The global outbreak of coronavirus disease 2019 (COVID-19) presents numerous obstacles for healthcare professionals. The present study aimed to evaluate and compare the role of serum biomarkers like- C-reactive protein (CRP), interleukin-6 (IL-6), and D-dimers in the severity of COVID-19 infection.

METHODOLOGY

A cross-sectional, observational retrospective pilot study was conducted in Udaipur, Rajasthan, wherein data was collected from 250 subjects, out of which, data of 100 subjects were included as per the inclusion criteria. The data was recorded retrospectively among the health professionals via Google Forms in Udaipur, Rajasthan.

RESULTS

There were 1 (1%), 3 (3%), 31 (31%) and 65 (65%) participants with minor elevation (0.3-1.0), moderate elevation (1-10), marked elevation (10-50) and severe elevation (>50) of CRP respectively. The difference between the groups was statistically highly significant with a significantly higher number of study participants with a severe elevation of CRP levels (χ = 107.84, < 0.001). The results showed that there was a significant difference between the groups with IL6 in 0-7 range while 96 (96%) study participants had >7 IL6, and the difference was statistically highly significant (2 = 84.640, 0.001).

CONCLUSION

In conclusion, the existing body of research indicates a discernible correlation between COVID-19 infection and the fluctuation of biomarker levels. This supplement has the potential to be utilised in clinical practice as a means of informing treatment decisions and determining the necessity of admission to the intensive care unit (ICU).

摘要

背景

2019年冠状病毒病(COVID-19)的全球爆发给医护人员带来了诸多障碍。本研究旨在评估和比较血清生物标志物如C反应蛋白(CRP)、白细胞介素-6(IL-6)和D-二聚体在COVID-19感染严重程度中的作用。

方法

在拉贾斯坦邦乌代布尔进行了一项横断面、观察性回顾性试点研究,从250名受试者中收集数据,其中100名受试者的数据符合纳入标准。数据通过谷歌表单在拉贾斯坦邦乌代布尔的卫生专业人员中进行回顾性记录。

结果

CRP轻度升高(0.3 - 1.0)、中度升高(1 - 10)、显著升高(10 - 50)和重度升高(>50)的参与者分别有1名(1%)、3名(3%)、31名(31%)和65名(65%)。组间差异具有高度统计学意义,CRP水平重度升高的研究参与者数量显著更多(χ = 107.84,< 0.001)。结果显示,IL6在0 - 7范围内的组间存在显著差异,而96名(96%)研究参与者的IL6 >7,差异具有高度统计学意义(2 = 84.640,0.001)。

结论

总之,现有研究表明COVID-19感染与生物标志物水平波动之间存在明显关联。本补充材料有潜力在临床实践中用于指导治疗决策和确定入住重症监护病房(ICU)的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348c/11329092/836d9c9987b0/JOMFP-28-205-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348c/11329092/e1c1e4771a34/JOMFP-28-205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348c/11329092/358a0595beba/JOMFP-28-205-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348c/11329092/052ad7099b51/JOMFP-28-205-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348c/11329092/836d9c9987b0/JOMFP-28-205-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348c/11329092/e1c1e4771a34/JOMFP-28-205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348c/11329092/358a0595beba/JOMFP-28-205-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348c/11329092/052ad7099b51/JOMFP-28-205-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348c/11329092/836d9c9987b0/JOMFP-28-205-g004.jpg

相似文献

1
Role of C-reactive protein, IL-6, and D-dimers in prediction of severity of coronavirus disease 2019: A pilot study.C反应蛋白、白细胞介素-6和D-二聚体在预测2019冠状病毒病严重程度中的作用:一项初步研究。
J Oral Maxillofac Pathol. 2024 Apr-Jun;28(2):205-210. doi: 10.4103/jomfp.jomfp_28_24. Epub 2024 Jul 11.
2
Correlation of Age, Gender, ABO Blood Group and Rh Factor in COVID-19 Infection: A Cross-Sectional Study in Udaipur, Rajasthan, India.COVID-19感染中年龄、性别、ABO血型和Rh因子的相关性:印度拉贾斯坦邦乌代布尔的一项横断面研究
Cureus. 2024 Apr 8;16(4):e57798. doi: 10.7759/cureus.57798. eCollection 2024 Apr.
3
Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds.基于炎症细胞因子谱的埃及 COVID-19 预测,以及某些海洋衍生化合物的 2 种潜在治疗效果。
Int Immunopharmacol. 2024 Jan 5;126:111072. doi: 10.1016/j.intimp.2023.111072. Epub 2023 Nov 24.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Understanding the Impact of COVID-19 on Roma Vulnerable Communities in Western Romania: Insights and Predictive Factors from a Retrospective Study.了解 COVID-19 对罗马尼亚西部罗姆人弱势社区的影响:回顾性研究的见解和预测因素。
Viruses. 2024 Mar 12;16(3):435. doi: 10.3390/v16030435.
6
Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.新型冠状病毒病(COVID-19)不同严重程度的炎症和非炎症指标的差异。
Infect Genet Evol. 2020 Nov;85:104511. doi: 10.1016/j.meegid.2020.104511. Epub 2020 Aug 26.
7
Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.沙利鲁单抗对比标准治疗用于住院 COVID-19 肺炎患者的早期治疗:SARTRE:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 16;21(1):794. doi: 10.1186/s13063-020-04633-3.
8
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.伴有确诊的 2019 冠状病毒病(COVID-19)感染住院患者肾素-血管紧张素-醛固酮系统阻滞剂管理(麦吉尔 RAAS-COVID-19):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):115. doi: 10.1186/s13063-021-05080-4.
9
Hyponatremia in Coronavirus Disease-19 Patients: A Retrospective Analysis.新型冠状病毒肺炎患者的低钠血症:一项回顾性分析
Can J Kidney Health Dis. 2021 Dec 22;8:20543581211067069. doi: 10.1177/20543581211067069. eCollection 2021.
10
Inflammatory laboratory findings associated with severe illness among hospitalized individuals with COVID-19 in Medan, Indonesia: a cross-sectional study.印度尼西亚棉兰住院 COVID-19 患者严重疾病相关的炎症实验室发现:一项横断面研究。
F1000Res. 2021 Dec 6;10:1246. doi: 10.12688/f1000research.74758.2. eCollection 2021.

本文引用的文献

1
A systematic review and meta-analysis of long COVID symptoms.长新冠症状的系统评价和荟萃分析。
Syst Rev. 2023 May 27;12(1):88. doi: 10.1186/s13643-023-02250-0.
2
Biomarkers in long COVID-19: A systematic review.新冠长期症状中的生物标志物:一项系统综述。
Front Med (Lausanne). 2023 Jan 20;10:1085988. doi: 10.3389/fmed.2023.1085988. eCollection 2023.
3
The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis.住院和非住院人群中“长新冠”的患病率及长期健康影响:一项系统评价与荟萃分析
EClinicalMedicine. 2022 Dec 1;55:101762. doi: 10.1016/j.eclinm.2022.101762. eCollection 2023 Jan.
4
Symptoms and risk factors for long COVID in non-hospitalized adults.非住院成年人的长新冠症状和风险因素。
Nat Med. 2022 Aug;28(8):1706-1714. doi: 10.1038/s41591-022-01909-w. Epub 2022 Jul 25.
5
The Role of Biomarkers in Hospitalized COVID-19 Patients With Systemic Manifestations.生物标志物在伴有全身表现的COVID-19住院患者中的作用
Biomark Insights. 2022 Jun 26;17:11772719221108909. doi: 10.1177/11772719221108909. eCollection 2022.
6
Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review.COVID-19 感染后遗症和长新冠综合征的性别差异:综述。
Curr Med Res Opin. 2022 Aug;38(8):1391-1399. doi: 10.1080/03007995.2022.2081454. Epub 2022 Jun 20.
7
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.COVID-19 住院幸存者 2 年后的健康结局:一项纵向队列研究。
Lancet Respir Med. 2022 Sep;10(9):863-876. doi: 10.1016/S2213-2600(22)00126-6. Epub 2022 May 11.
8
Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review.全球新型冠状病毒病 2019(COVID-19)后状况或长新冠的流行率:一项荟萃分析和系统评价。
J Infect Dis. 2022 Nov 1;226(9):1593-1607. doi: 10.1093/infdis/jiac136.
9
Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms.新冠病毒病的长期后遗症:对新冠后症状进行的为期一年随访研究的系统评价和荟萃分析
Pathogens. 2022 Feb 19;11(2):269. doi: 10.3390/pathogens11020269.
10
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis.COVID-19 的 50 多种长期影响:系统评价和荟萃分析。
Sci Rep. 2021 Aug 9;11(1):16144. doi: 10.1038/s41598-021-95565-8.